NCT02530073View on ClinicalTrials.gov

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2030

Conditions
Congenital Diaphragmatic Hernias
Interventions
DEVICE

Fetoscopic Endoluminal Tracheal Occlusion (FETO)

This study will position and remove an endoluminal tracheal balloon in utero (FETO) to study the feasibility of implementing FETO therapy in the most severe group of fetuses with left CDH and observed/expected length head ratio \<25% (O/E LHR).

Trial Locations (1)

06106

RECRUITING

Connecticut Children's Medical Center, Hartford

All Listed Sponsors
lead

Connecticut Children's Medical Center

OTHER